• Profile
Close

Efficacy and safety of combination therapy with sodium-glucose transporter 2 inhibitors and renin-angiotensin system blockers in patients with type 2 diabetes: A systematic review and meta-analysis

Nephrology Dialysis Transplantation Feb 25, 2021

Tian B, Deng Y, Cai Y, et al. - Through searching PubMed, EMBASE, Web of Science and Cochrane Library from their inception to May 2020, researchers sought to assess the efficacy and safety of combination therapy in patients with T2DM with SGLT2 inhibitors and RAS blockers, such as ACEI/ARB. Seven studies including 1757 patients have been analyzed. The combination therapy with SGLT2 inhibitors and ACEI/ARB in T2DM was effective and well-tolerated compared with ACEI/ARB alone and was able to achieve additional effects, including better blood pressure control, improved renal outcomes, alleviation of long-term renal function, and decreased blood glucose and body weight. An increased risk of hypoglycemia was demonstrated by combination therapy.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay